- News & Features
|Kunal Gandhi, MD, MPH
Dr. Kunal Gandhi is currently an Associate Director and Research Medical Lead in the US Medical Affairs department at Bristol-Myers Squibb. In addition, he is an adjunct faculty at the Rutgers Robert Wood Johnson Medical School in New Brunswick, New Jersey. He is currently supporting medical and research activities for the immunoscience area, with a focus on chronic inflammatory disorders such as Rheumatoid Arthritis.
Prior to joining BMS, Dr Gandhi worked as a Senior Manager within the North American Vaccines Division at GlaxoSmithKlein (GSK), where he provided strategic and technical advice on the clinical development, product strategy and commercial decision making for various vaccine and biological development programs. Dr. Gandhi has also served as a full-time research faculty at Rutgers Robert Wood Johnson Medical School for 6+ years. His research work focused on assessing effective psychopharmacologic treatments available for addiction and co-occurring mental health disorders.
Evaluation of the patient reported outcomes (PROs) and development of methodology for designing large observation studies are among Dr. Gandhi’s research interests.
When asked, “Why is patient-centered and patient-powered research necessary in order to advance our understanding of rheumatological conditions?”, Dr. Gandhi responded,
“Patient-centered and patient-powered research has become extremely important, as it not only allows patients to get more actively involved with their rheumatologic conditions, but also ensure that patient values drive clinical decision making. It also allows patients to engage more actively in healthy advocacy and governance involved with their disease condition.”